1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2013 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures

Complete report $3,950. DataPack (test volumes, sales forecasts, supplier shares) $2,500.
Summary
This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Public Health Laboratories
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

• Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
• Examines market applications of Molecular Diagnostics, Immundiagnostics, IT and other emerging technologies.
• Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho- Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
• Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
• Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including Venture Planning Group's proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 277 pages and 31 tables

Table Of Contents

2013 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures
Table of Contents

I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers'
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VI. Spain: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VII. UK: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VIII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers6. Major Types of Distributors
7. Market Segmentation
IX. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
X. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio/Innogenetics
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako



List of Tables

Major Companies Developing or Marketing AIDS Tests
France: HIV or HIV-1/2 Test Volume and Sales Forecasts
By Market Segment
France: HIV Ag Test Volume and Sales Forecasts
By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Germany: HIV or HIV-1/2 Test Volume and Sales Forecasts
By Market Segment
Germany: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Germany: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment
Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares
Of Major Suppliers
Italy: HIV or HIV-1/2 Test Volume and Sales Forecasts
By Market Segment
Italy: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Italy: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market SegmentItaly: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Spain: HIV or HIV-1/2 Test Volume and Sales Forecasts
By Market Segment
Spain: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
UK: HIV or HIV-1/2 Test Volume and Sales Forecasts
By Market Segment
UK: HIV Ag Test Volume and Sales Forecasts
By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume
And Sales Forecasts by Market Segment
UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.